Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 3, 2010, Pages 474-479

  Lu, Feng ^a,b   Lim, Chae Seung ^c   Nam, Deok Hwa ^c   Kim, Kwonkee ^d   Lin, Khin ^e   Kim, Tong Soo ^f   Lee, Hyeong Woo ^g,h   Chen, Jun Hu ^a,i   Wang, Yue ^a,i   Sattabongkot, Jetsumon ^j   Han, Eun Taek ^a  

^a Kangwon National University College of Medicine   (South Korea)

^b JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^c Korea University College of Medicine   (South Korea)

^d Gachon University College of Medicine   (South Korea)

^e DEPARTMENT OF HEALTH   (Myanmar)

^f Inha University School of Medicine   (South Korea)

^g Korea Centers for Disease Control and Prevention   (South Korea)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ INSTITUTE OF MATERIA MEDICA   (China)

^j ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE PLUS SULFADOXINE; FOLIC ACID ANTAGONIST; PRIMER DNA;

AMINO ACID SEQUENCE; ARTICLE; ENDEMIC DISEASE; HUMAN; KOREA; MALARIA; MYANMAR; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; POINT MUTATION; THAILAND; ALLELE; ANIMAL; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; GENETICS; MUTATION; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION;

PLASMODIUM VIVAX;

ALLELES; ANIMALS; BASE SEQUENCE; DIHYDROPTEROATE SYNTHASE; DNA PRIMERS; DRUG RESISTANCE; ENDEMIC DISEASES; FOLIC ACID ANTAGONISTS; HUMANS; MALARIA, VIVAX; MUTATION; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 77957062531     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0004     Document Type: Article

References (34)

1. Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97-106. (Pubitemid 32552576)
2. Yeshiwondim AK, Tekle AH, Dengela DO, Yohannes AM, Teklehaimanot A, 2010. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia. Acta Trop 113: 105-113.
3. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo HA, 2009. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555-566.
4. Thimasarn K, 1999. Malaria Control Program in Thailand. Malikul S, ed. Bangkok, Thailand: Malaria Division, Department of Communicable Disease Control, Ministry of Public Health, Thailand, 88-102.
5. Imwong M, Pukrittayakamee S, Renia L, Letourneur F, Charlieu JP, Leartsakulpanich U, Looareesuwan S, White NJ, Snounou G, 2003. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob Agents Chemother 47: 1514-1521. (Pubitemid 36548531)
6. Smithuis FM, Monti F, Grundl M, Oo AZ, Kyaw TT, Phe O, White NJ, 1997. Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/ sulfadoxine and mefloquine in western Myanmar. Trans R Soc Trop Med Hyg 91: 468-472. (Pubitemid 27421246)
7. Smithuis F, Shahmanesh M, Kyaw MK, Savran O, Lwin S, White NJ, 2004. Comparison of chloroquine, sulfadoxine/ pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar. Trop Med Int Health 9: 1184-1190. (Pubitemid 39573990)
8. Guthmann JP, Pittet A, Lesage A, Imwong M, Lindegardh N, Min Lwin M, Zaw T, Annerberg A, de Radigues X, Nosten F, 2008. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar. Trop Med Int Health 13: 91-98. (Pubitemid 351271394)
9. Imwong M, Pukrittayakamee S, Pongtavornpinyo W, Nakeesathit S, Nair S, Newton P, Nosten F, Anderson TJ, Dondorp A, Day NP, White NJ, 2008. Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar. Antimicrob Agents Chemother 52: 2657-2659. (Pubitemid 351915703)
10. Liang GL, Sun XD, Wang J, Zhang ZX, 2009. Sensitivity of Plasmodium vivax to chloroquine in Laza City, Myanmar. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 27: 175-176.
11. Na BK, Lee HW, Moon SU, In TS, Lin K, Maung M, Chung GT, Lee JK, Kim TS, Kong Y, 2005. Genetic variations of the dihydrofolate reductase gene of Plasmodium vivax in Mandalay Division, Myanmar. Parasitol Res 96: 321-325.
12. Kim C, Shin DC, Yong TS, Oh DK, Kim RK, Park K, Suh IL, 2006. Chemoprophylaxis and the epidemiological characteristics of re-emergent P. vivax malaria in the Republic of Korea. Bull World Health Organ 84: 827-834. (Pubitemid 44610118)
13. Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM, 2001. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol 17: 582-588.
14. Young MD, Burgess RW, 1959. Pyrimethamine resistance in Plasmodium vivax malaria. Bull World Health Organ 20: 27-36.
15. Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh le N, Maguire J, Bell D, O'Neil MT, Cheng Q, 2006. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am J Trop Med Hyg 75: 617-621. (Pubitemid 46941264)
16. Rungsihirunrat K, Na-Bangchang K, Hawkins VN, Mungthin M, Sibley CH, 2007. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand. Am J Trop Med Hyg 76: 1057-1065. (Pubitemid 351837866)
17. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-568.
18. Tjitra E, Baker J, Suprianto S, Cheng Q, Anstey NM, 2002. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine- pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob Agents Chemother 46: 3947-3953. (Pubitemid 35403273)
19. Korsinczky M, Fischer K, Chen N, Baker J, Rieckmann K, Cheng Q, 2004. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. Antimicrob Agents Chemother 48: 2214-2222. (Pubitemid 38691621)
20. Hawkins VN, Joshi H, Rungsihirunrat K, Na-Bangchang K, Sibley CH, 2007. Antifolates can have a role in the treatment of Plasmodium vivax. Trends Parasitol 23: 213-222. (Pubitemid 46621225)
21. Leartsakulpanich U, Imwong M, Pukrittayakamee S, White NJ, Snounou G, Sirawaraporn W, Yuthavong Y, 2002. Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax. Mol Biochem Parasitol 119: 63-73. (Pubitemid 34038026)
22. de Pecoulas PE, Tahar R, Ouatas T, Mazabraud A, Basco LK, 1998. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol Biochem Parasitol 92: 265-273.
23. Lee KS, Kim TH, Kim ES, Lim HS, Yeom JS, Jun G, Park JW, 2009. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg 80: 215-217.
24. Brega S, de Monbrison F, Severini C, Udomsangpetch R, Sutanto I, Ruckert P, Peyron F, Picot S, 2004. Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrob Agents Chemother 48: 2581-2587. (Pubitemid 38823428)
25. Li J, Collins WE, Wirtz RA, Rathore D, Lal A, McCutchan TF, 2001. Geographic subdivision of the range of the malaria parasite Plasmodium vivax. Emerg Infect Dis 7: 35-42. (Pubitemid 32173331)
26. Marfurt J, de Monbrison F, Brega S, Barbollat L, Muller I, Sie A, Goroti M, Reeder JC, Beck HP, Picot S, Genton B, 2008. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1. J Infect Dis 198: 409-417.
27. Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G, 2003. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. Am J Trop Med Hyg 69: 247-252.
28. Triglia T, Cowman AF, 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7149-7153. (Pubitemid 24226820)
29. Triglia T, Cowman AF, 1999. The mechanism of resistance to sulfa drugs in Plasmodium falciparum. Drug Resist Updat 2: 15-19. (Pubitemid 29217090)
30. Triglia T, Wang P, Sims PF, Hyde JE, Cowman AF, 1998. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J 17: 3807-3815. (Pubitemid 28333967)
31. Rungsihirunrat K, Sibley CH, Mungthin M, Na-Bangchang K, 2008. Geographical distribution of amino acid mutations in Plasmodium vivax DHFR and DHPS from malaria endemic areas of Thailand. Am J Trop Med Hyg 78: 462-467. (Pubitemid 351845198)
32. Menegon M, Majori G, Severini C, 2006. Genetic variations of the Plasmodium vivax dihydropteroate synthase gene. Acta Trop 98: 196-199. (Pubitemid 43783138)
33. Hawkins VN, Suzuki SM, Rungsihirunrat K, Hapuarachchi HC, Maestre A, Na-Bangchang K, Sibley CH, 2009. Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase. Am J Trop Med Hyg 81: 348-355.
34. Imwong M, Pukrittayakamee S, Cheng Q, Moore C, Looareesuwan S, Snounou G, White NJ, Day NP, 2005. Limited polymorphism in the dihydropteroate synthetase gene ( dhps ) of Plasmodium vivax isolates from Thailand. Antimicrob Agents Chemother 49: 4393-4395. (Pubitemid 41400997)